Exome sequencing focuses on the protein-coding regions of the genome—known as exons—which represent only about 1–2% of the DNA but contain the majority of disease-related variants. By targeting these regions, exome sequencing provides a powerful and cost-effective approach to uncovering genetic mutations that influence health, disease susceptibility, and treatment outcomes.
At AVecGen, we deliver high-quality Exome Sequencing Analysis using advanced sequencing platforms and robust bioinformatics pipelines. Our service enables researchers to:
•     Identify genetic variants linked to insecticide resistance, pathogen adaptation, or human disease.
•     Detect rare mutations that may not be captured by targeted panels.
•     Perform comparative studies across populations to understand genetic diversity and evolutionary dynamics.
•     Accelerate discovery of biomarkers and therapeutic targets for improved disease management.

 Whether you are working with clinical samples, vector populations, or experimental models, our team ensures precise sequencing, comprehensive variant analysis, and clear reporting tailored to your research goals.